Roivant Sciences Ltd. (NASDAQ:ROIV) Given Average Rating of “Moderate Buy” by Analysts

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average […]

Leave a Reply

Your email address will not be published.

Previous post Tadao Tsubata Sells 282,000 Shares of Dome Gold Mines Ltd (ASX:DME) Stock
Next post Mercer International Inc. (NASDAQ:MERC) Receives $9.67 Consensus Price Target from Brokerages